ACADIA Pharmaceuticals(ACAD) - 2023 Q2 - Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Jessica Tieszen - Associate Director of Investor Relations Mark Johnson - Vice President of Investor Relations Steve Davis - Chief Executive Officer Brendan Teehan - Chief Operating Officer, Head of Commercial Doug Williamson - Head of Research & Development Mark Schneyer - Chief Financial Officer Kathie Bishop - Head of Rare Diseases and External Innovation Conference Call Participants ...